SANKAR NAVANEETHAN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    R01DK101500     (NAVANEETHAN, SANKAR DASS)Sep 22, 2014 - Jul 31, 2019
    NIH/NIDDK
    Visceral Adiposity and Physical Fitness in CKD
    Role: Principal Investigator

    I01HX002917     (VIRANI, SALIM S)Oct 1, 2020 - Sep 30, 2024
    VA
    Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 Jan 01; 36(1):129-136. PMID: 31641775.
      Citations:    Fields:    
    2. Walther CP, Winkelmayer WC, Richardson PA, Virani SS, Navaneethan SD. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2020 Dec 25. PMID: 33367872.
      Citations:    Fields:    
    3. Grams ME, Surapaneni A, Appel LJ, Lash JP, Hsu J, Diamantidis CJ, Rosas SE, Fink JC, Scialla JJ, Sondheimer J, Hsu CY, Cheung AK, Jaar BG, Navaneethan S, Cohen DL, Schrauben S, Xie D, Rao P, Feldman HI. Clinical events and patient-reported outcome measures during CKD progression: findings from the CRIC study. Nephrol Dial Transplant. 2020 Dec 16. PMID: 33326030.
      Citations:    Fields:    
    4. Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Ann Intern Med. 2020 Nov 10. PMID: 33166222.
      Citations:    Fields:    
    5. Chung EY, Ruospo M, Natale P, Bolignano D, Navaneethan SD, Palmer SC, Strippoli GF. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 10 27; 10:CD007004. PMID: 33107592.
      Citations: 1     Fields:    Translation:Humans
    6. Ali S, Ajmal MS, Navaneethan SD. Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney disease. Curr Opin Nephrol Hypertens. 2020 09; 29(5):453-456. PMID: 32701601.
      Citations:    Fields:    
    7. Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, Sondheimer JH, Steigerwalt SP, Wilson FP, Wolf M, Feldman HI. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 Jan; 77(1):56-73.e1. PMID: 32866540.
      Citations:    Fields:    
    8. Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA, Rahman M, Rao PS, Schold JD, Shafi T, Taliercio JJ, Townsend RR, Feldman HI. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 Jan; 77(1):44-55. PMID: 32798563.
      Citations:    Fields:    
    9. Hu EA, Coresh J, Anderson CAM, Appel LJ, Grams ME, Crews DC, Mills KT, He J, Scialla J, Rahman M, Navaneethan SD, Lash JP, Ricardo AC, Feldman HI, Weir MR, Shou H, Rebholz CM. Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2020 Aug 05. PMID: 32768632.
      Citations:    Fields:    
    10. de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Zoungas S, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Rossing P. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020 10; 98(4):839-848. PMID: 32653403.
      Citations: 1     Fields:    
    11. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Naik AD, Winkelmayer WC. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334. PMID: 32371535.
      Citations: 1     Fields:    
    12. Triozzi JL, Niu J, Walther CP, Winkelmayer WC, Navaneethan SD. [Hospitalization and Critical Illness in Chronic Kidney Disease]. Cardiorenal Med. 2020; 10(5):302-312. PMID: 32316008.
      Citations:    Fields:    
    13. Ghazi L, Yaffe K, Tamura MK, Rahman M, Hsu CY, Anderson AH, Cohen JB, Fischer MJ, Miller ER, Navaneethan SD, He J, Weir MR, Townsend RR, Cohen DL, Feldman HI, Drawz PE. Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clin J Am Soc Nephrol. 2020 04 07; 15(4):455-464. PMID: 32217634.
      Citations: 1     Fields:    
    14. Walther CP, Nambi V, Hanania NA, Navaneethan SD. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945. PMID: 32199709.
      Citations:    Fields:    Translation:Humans
    15. Malin SK, Navaneethan SD, Fealy CE, Scelsi A, Huang H, Rocco M, Kirwan JP. Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease. Obes Sci Pract. 2020 Jun; 6(3):307-312. PMID: 32523720.
      Citations:    
    16. Walther CP, Richardson PA, Virani SS, Winkelmayer WC, Navaneethan SD. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319. PMID: 30053252.
      Citations: 2     Fields:    Translation:Humans
    17. Navaneethan SD, Yan J, Deswal A. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis. 2020 05; 75(5):690-692. PMID: 32008859.
      Citations:    Fields:    Translation:Humans
    18. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181. PMID: 31962311.
      Citations:    Fields:    
    19. Airy M, Lenihan CR, Ding VY, Montez-Rath ME, Cheng J, Navaneethan SD, Wasse H, Winkelmayer WC. Association Between Type of Vascular Access Used in Hemodialysis Patients and Subsequent Kidney Transplant Outcomes. Kidney Med. 2019 Nov-Dec; 1(6):383-390. PMID: 32734218.
      Citations:    
    20. Vangala C, Niu J, Montez-Rath ME, Yan J, Navaneethan SD, Winkelmayer WC. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360. PMID: 31606233.
      Citations: 3     Fields:    Translation:Humans
    21. Shah A, Navaneethan SD. Editorial: Novel therapeutic options for management of electrolyte disorders. Curr Opin Nephrol Hypertens. 2019 09; 28(5):407-408. PMID: 31232711.
      Citations:    Fields:    
    22. Norton JM, Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P. Development and Validation of a Pragmatic Electronic Phenotype for CKD. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1306-1314. PMID: 31405830.
      Citations: 8     Fields:    Translation:Humans
    23. Erickson KF, Navaneethan SD. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127. PMID: 31345841.
      Citations:    Fields:    Translation:Humans
    24. Ali S, Dave N, Virani SS, Navaneethan SD. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Curr Atheroscler Rep. 2019 06 22; 21(9):32. PMID: 31230129.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    25. Navaneethan SD, Shao J, Buysse J, Bushinsky DA. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1011-1020. PMID: 31196951.
      Citations: 4     Fields:    Translation:Humans
    26. Walther CP, Winkelmayer WC, Niu J, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658. PMID: 31160142.
      Citations: 1     Fields:    Translation:Humans
    27. Hsu RK, Hsu CY, McCulloch CE, Yang J, Anderson AH, Chen J, Feldman HI, He J, Liu KD, Navaneethan SD, Porter AC, Rahman M, Tan TC, Wilson FP, Xie D, Zhang X, Go AS. Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study. Clin Kidney J. 2020 Feb; 13(1):55-62. PMID: 32082553.
      Citations:    
    28. Anumudu S, Airy M, Erickson KF, Navaneethan SD, Chang TI, Winkelmayer WC, Niu J. Predialysis Nephrology Care and Incident Atrial Fibrillation in Older Patients With ESKD Initiating Dialysis. Kidney Int Rep. 2019 May; 4(5):679-687. PMID: 31080923.
      Citations:    
    29. Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980. PMID: 30686093.
      Citations: 1     Fields:    Translation:Humans
    30. Navaneethan SD. Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss. Circulation. 2019 01 15; 139(3):376-379. PMID: 30640548.
      Citations: 1     Fields:    Translation:HumansAnimals
    31. Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019 01 10; 364:k5301. PMID: 30630856.
      Citations: 16     Fields:    Translation:Humans
    32. Navaneethan SD, Akeroyd JM, Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Ballantyne C, Winkelmayer WC, Ramanathan V, Virani SS. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850. PMID: 30498000.
      Citations: 2     Fields:    Translation:Humans
    33. Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481. PMID: 30472701.
      Citations: 9     Fields:    Translation:Humans
    34. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104. PMID: 30463082.
      Citations: 1     Fields:    Translation:Humans
    35. Niu J, Shah MK, Perez JJ, Airy M, Navaneethan SD, Turakhia MP, Chang TI, Winkelmayer WC. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331. PMID: 30449517.
      Citations: 1     Fields:    Translation:Humans
    36. Walther CP, Shah M, Navaneethan SD. Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure Control. Am J Kidney Dis. 2019 01; 73(1):4-7. PMID: 30424915.
      Citations:    Fields:    Translation:Humans
    37. Bansal N, Xie D, Sha D, Appel LJ, Deo R, Feldman HI, He J, Jamerson K, Kusek JW, Messe S, Navaneethan SD, Rahman M, Ricardo AC, Soliman EZ, Townsend R, Go AS. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2018 12; 29(12):2859-2869. PMID: 30377231.
      Citations: 4     Fields:    Translation:Humans
    38. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40. PMID: 30368506.
      Citations:    Fields:    Translation:Humans
    39. Vangala C, Niu J, Lenihan CR, Mitch WE, Navaneethan SD, Winkelmayer WC. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541. PMID: 30262672.
      Citations: 3     Fields:    Translation:Humans
    40. Ali S, Dave N, Navaneethan SD. Emerging therapeutic options for management of anaemia in with patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 09; 27(5):329-330. PMID: 29939850.
      Citations:    Fields:    
    41. Airy M, Chang TI, Ding VY, Goldstein BA, Bansal N, Niu J, Navaneethan SD, Turakhia MP, Winkelmayer WC. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597. PMID: 29145634.
      Citations: 4     Fields:    Translation:Humans
    42. Shurrab M, Ko DT, Zayed Y, Navaneethan SD, Yadak N, Yaseen A, Kaoutskaia A, Qamhia W, Hamdan Z, Haj-Yahia S, Lee DS, Newman D, Healey JS, Harvey P, Crystal E. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018 Oct; 53(1):123-129. PMID: 30058056.
      Citations: 1     Fields:    Translation:Humans
    43. Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45. PMID: 30048961.
      Citations: 1     Fields:    Translation:Humans
    44. Walther CP, Niu J, Winkelmayer WC, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14). PMID: 29980520.
      Citations: 2     Fields:    Translation:Humans
    45. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622. PMID: 29784611.
      Citations:    Fields:    Translation:Humans
    46. Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, Foster E, Go AS, He J, Keane MG, Kusek JW, Mohler E, Navaneethan SD, Rahman M, Hsu CY. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018 09; 72(3):390-399. PMID: 29784617.
      Citations: 6     Fields:    Translation:Humans
    47. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7. PMID: 29699917.
      Citations: 3     Fields:    Translation:Humans
    48. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018 06; 93(6):1442-1451. PMID: 29605094.
      Citations: 18     Fields:    Translation:Humans
    49. Walther CP, Chandra A, Navaneethan SD. Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease. Curr Opin Nephrol Hypertens. 2018 01; 27(1):16-22. PMID: 29045334.
      Citations: 1     Fields:    Translation:Humans
    50. Navaneethan SD, Mandayam S. Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease. Kidney Int Rep. 2018 Mar; 3(2):244-246. PMID: 29725628.
      Citations:    
    51. Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 05; 71(5):657-665. PMID: 29217305.
      Citations: 7     Fields:    Translation:Humans
    52. Qureshi S, Lorch R, Navaneethan SD. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease. Curr Hypertens Rep. 2017 Oct 18; 19(11):92. PMID: 29046987.
      Citations: 1     Fields:    Translation:Humans
    53. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322. PMID: 29032376.
      Citations: 3     Fields:    Translation:Humans
    54. Walther CP, Whaley-Connell A, Navaneethan SD. Emerging therapeutic options for managing diabetic kidney disease. Curr Opin Nephrol Hypertens. 2017 09; 26(5):335-337. PMID: 28548994.
      Citations:    Fields:    
    55. Rehman H, Akeroyd JM, Ramsey D, Ahmed ST, Merchant AT, Navaneethan SD, Petersen LA, Virani SS. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clin Cardiol. 2017 Nov; 40(11):1055-1060. PMID: 28841246.
      Citations:    Fields:    Translation:Humans
    56. Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clin J Am Soc Nephrol. 2017 09 07; 12(9):1409-1417. PMID: 28793999.
      Citations: 2     Fields:    Translation:Humans
    57. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427. PMID: 28778854.
      Citations: 11     Fields:    Translation:Humans
    58. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281. PMID: 28750929.
      Citations: 5     Fields:    Translation:Humans
    59. Navaneethan SD, Virani SS. Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk. J Am Heart Assoc. 2017 07 14; 6(7). PMID: 28710179.
      Citations:    Fields:    Translation:Humans
    60. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210. PMID: 27220754.
      Citations: 5     Fields:    Translation:Humans
    61. Vangala C, Lenihan CR, Montez-Rath ME, Nair SS, Navaneethan SD, Ramanathan V, Winkelmayer WC. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145. PMID: 28460645.
      Citations:    Fields:    Translation:Humans
    62. Kalantar-Zadeh K, Crowley ST, Beddhu S, Chen JLT, Daugirdas JT, Goldfarb DS, Jin A, Kovesdy CP, Leehey DJ, Moradi H, Navaneethan SD, Norris KC, Obi Y, O'Hare A, Shafi T, Streja E, Unruh ML, Vachharajani TJ, Weisbord S, Rhee CM. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017 05; 30(3):251-261. PMID: 28421638.
      Citations: 11     Fields:    Translation:Humans
    63. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 02 16; 376(7):641-651. PMID: 28199805.
      Citations: 279     Fields:    Translation:Humans
    64. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198. PMID: 28196649.
      Citations: 6     Fields:    Translation:Humans
    65. Chang AR, Grams ME, Navaneethan SD. Bariatric Surgery and Kidney-Related Outcomes. Kidney Int Rep. 2017 Mar; 2(2):261-270. PMID: 28439568.
      Citations:    
    66. Chirakarnjanakorn S, Navaneethan SD, Francis GS, Tang WH. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol. 2017 Apr 01; 232:12-23. PMID: 28108129.
      Citations: 12     Fields:    Translation:Humans
    67. Walther CP, Navaneethan SD. Inflammation as a Therapeutic Target To Improve Vascular Function in Kidney Disease. J Am Soc Nephrol. 2017 03; 28(3):723-725. PMID: 28049650.
      Citations: 2     Fields:    Translation:Humans
    68. Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney Int. 2017 03; 91(3):711-719. PMID: 28017325.
      Citations: 24     Fields:    Translation:HumansCells
    69. Airy M, Winkelmayer WC, Navaneethan SD. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670. PMID: 27772629.
      Citations: 1     Fields:    Translation:Humans
    70. Kirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB. A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov; 146(11):2244-2251. PMID: 27798329.
      Citations: 21     Fields:    Translation:Humans
    71. Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56. PMID: 27434583.
      Citations: 17     Fields:    Translation:Humans
    72. Agrawal V, Navaneethan SD. Bariatric surgery for obesity-associated decline in kidney function: filling the knowledge gap? Kidney Int. 2016 07; 90(1):28-30. PMID: 27312446.
      Citations: 2     Fields:    Translation:Humans
    73. Yan J, Navaneethan SD. Copeptin and Decline in Kidney Function. Am J Nephrol. 2016; 44(1):19-21. PMID: 27348731.
      Citations: 1     Fields:    Translation:Humans
    74. de Boer IH, Kovesdy CP, Navaneethan SD, Peralta CA, Tuot DS, Vazquez MA, Crews DC. Pragmatic Clinical Trials in CKD: Opportunities and Challenges. J Am Soc Nephrol. 2016 Oct; 27(10):2948-2954. PMID: 27283497.
      Citations: 16     Fields:    Translation:Humans
    75. Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016 May 31; (5):CD004683. PMID: 27243372.
      Citations: 4     Fields:    Translation:Humans
    76. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21. PMID: 27130720.
      Citations: 7     Fields:    Translation:Humans
    77. Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016 07; 30(5):944-50. PMID: 27114387.
      Citations: 20     Fields:    Translation:Humans
    78. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46. PMID: 26891053.
      Citations: 6     Fields:    Translation:Humans
    79. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82. PMID: 26880461.
      Citations: 13     Fields:    Translation:Humans
    80. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016 Jan 12; 315(2):164-74. PMID: 26757465.
      Citations: 81     Fields:    Translation:Humans
    81. Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK, Kirwan JP. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015; 42(4):274-81. PMID: 26495987.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    82. Andalib A, Aminian A, Khorgami Z, Navaneethan SD, Schauer PR, Brethauer SA. Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc. 2016 06; 30(6):2583-91. PMID: 26416373.
      Citations: 10     Fields:    Translation:Humans
    83. Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2016 Mar; 27(3):877-86. PMID: 26386072.
      Citations: 13     Fields:    Translation:Humans
    84. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS. GFR Estimation Using ß-Trace Protein and ß2-Microglobulin in CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8. PMID: 26362696.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    85. Sharma S, Navaneethan SD. Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line. Am J Nephrol. 2015; 42(1):54-6. PMID: 26303823.
      Citations:    Fields:    Translation:Humans
    86. Navaneethan SD, Whaley-Connell A. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1501-3. PMID: 26276139.
      Citations:    Fields:    Translation:Humans
    87. Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, Steigerwalt SP, Townsend RR, Feldman HI. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clin J Am Soc Nephrol. 2015 Nov 06; 10(11):2073-83. PMID: 26265715.
      Citations: 18     Fields:    Translation:Humans
    88. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63. PMID: 26228532.
      Citations: 23     Fields:    Translation:Humans
    89. Saeed F, Adil MM, Vidal GA, Piracha BH, Nahab F, Khan AS, Navaneethan SD. Outcomes of transient ischemic attack in maintenance dialysis patients and those with chronic kidney disease. Nephrol Dial Transplant. 2016 Jan; 31(1):128-32. PMID: 26160895.
      Citations:    Fields:    Translation:Humans
    90. Navaneethan SD, Dweik RA. Elevated pulmonary pressure: A novel risk marker in kidney disease? Kidney Int. 2015 Jul; 88(1):7-9. PMID: 26126087.
      Citations: 2     Fields:    Translation:Humans
    91. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27. PMID: 26111859.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    92. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8. PMID: 26077569.
      Citations: 15     Fields:    Translation:Humans
    93. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20. PMID: 26045089.
      Citations: 26     Fields:    Translation:Humans
    94. Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ. Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015 May 04; (5):CD007910. PMID: 25938479.
      Citations: 1     Fields:    Translation:Humans
    95. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03; 16:69. PMID: 26024966.
      Citations: 9     Fields:    Translation:Humans
    96. Navaneethan SD, Boulware LE, Sedor JR. Patients as stakeholders in setting kidney disease research priorities. Am J Kidney Dis. 2015 May; 65(5):641-3. PMID: 25919496.
      Citations:    Fields:    Translation:Humans
    97. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan SD. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7. PMID: 25800550.
      Citations: 3     Fields:    Translation:Humans
    98. Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015 Feb; 65(2):345-7. PMID: 25458664.
      Citations: 11     Fields:    Translation:Humans
    99. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol. 2014 Dec 05; 9(12):2095-103. PMID: 25381342.
      Citations: 16     Fields:    Translation:Humans
    100. Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7. PMID: 25323128.
      Citations: 4     Fields:    Translation:Humans
    101. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83. PMID: 25249672.
      Citations: 166     Fields:    Translation:Humans
    102. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33. PMID: 25257325.
      Citations: 118     Fields:    Translation:Humans
    103. Saab G, Lam M, Navaneethan SD, Slatopolsky E. Should monitoring of fibroblast growth factor-23 levels in dialysis patients be a part of routine clinical practice? Semin Dial. 2014 Nov-Dec; 27(6):565-8. PMID: 25040017.
      Citations:    Fields:    Translation:Humans
    104. Saab G, Navaneethan SD, Slatopolsky E. Targeting parathyroid hormone levels in dialysis patients. Semin Dial. 2014 Nov-Dec; 27(6):562-5. PMID: 25040125.
      Citations: 1     Fields:    Translation:Humans
    105. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014 Jul 08; 15:108. PMID: 25005601.
      Citations: 16     Fields:    Translation:Humans
    106. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25. PMID: 24887302.
      Citations: 4     Fields:    Translation:Humans
    107. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014 May 31; (5):CD007784. PMID: 24880031.
      Citations: 42     Fields:    Translation:Humans
    108. Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2014 Apr 29; (4):CD007004. PMID: 24782282.
      Citations: 35     Fields:    Translation:Humans
    109. Hawkins M, Newman AB, Madero M, Patel KV, Shlipak MG, Cooper J, Johansen KL, Navaneethan SD, Shorr RI, Simonsick EM, Fried LF. TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults. J Phys Act Health. 2015 Apr; 12(4):561-8. PMID: 24762526.
      Citations: 5     Fields:    Translation:Humans
    110. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74. PMID: 24726629.
      Citations: 11     Fields:    Translation:Humans
    111. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96. PMID: 24714513.
      Citations: 12     Fields:    Translation:Humans
    112. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22; 370(21):2002-13. PMID: 24679060.
      Citations: 423     Fields:    Translation:Humans
    113. Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2014 Mar 31; (3):CD009297. PMID: 24683046.
      Citations: 7     Fields:    Translation:Humans
    114. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63. PMID: 24578332.
      Citations: 11     Fields:    Translation:Humans
    115. Wing MR, Yang W, Teal V, Navaneethan S, Tao K, Ojo A, Guzman NN, Reilly M, Wolman M, Rosas SE, Cuevas M, Fischer M, Lustigova E, Master SR, Xie D, Appleby D, Joffe M, Kusek J, Feldman HI, Raj DS. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Obesity (Silver Spring). 2014 May; 22(5):1359-66. PMID: 24415732.
      Citations: 2     Fields:    Translation:Humans
    116. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15. PMID: 24508475.
      Citations: 17     Fields:    Translation:Humans
    117. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014 Jan 28; (1):CD005019. PMID: 24470059.
      Citations: 15     Fields:    Translation:Humans
    118. Kelly KR, Navaneethan SD, Solomon TP, Haus JM, Cook M, Barkoukis H, Kirwan JP. Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. Med Sci Sports Exerc. 2014; 46(5):920-6. PMID: 24614337.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    119. Stephen R, Jolly SE, Nally JV, Navaneethan SD. Albuminuria: when urine predicts kidney and cardiovascular disease. Cleve Clin J Med. 2014 Jan; 81(1):41-50. PMID: 24391106.
      Citations: 8     Fields:    Translation:Humans
    120. Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP. Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. J Nutr Health Aging. 2014; 18(6):608-15. PMID: 24950152.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    121. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6. PMID: 24253541.
      Citations: 2     Fields:    Translation:Humans
    122. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013 Sep 11; (9):CD004289. PMID: 24022428.
      Citations: 27     Fields:    Translation:Humans
    123. Navaneethan SD, Bravo EL. Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers? Clin J Am Soc Nephrol. 2013 Oct; 8(10):1637-9. PMID: 23929926.
      Citations: 2     Fields:    Translation:Humans
    124. Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013 Sep; 13(9):2342-51. PMID: 23865821.
      Citations: 11     Fields:    Translation:Humans
    125. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10. PMID: 23769134.
      Citations: 19     Fields:    Translation:Humans
    126. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70. PMID: 23669002.
      Citations: 6     Fields:    Translation:Humans
    127. Garg N, Thomas G, Jackson G, Rickard J, Nally JV, Tang WH, Navaneethan SD. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1293-303. PMID: 23660183.
      Citations: 12     Fields:    Translation:Humans
    128. Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ, Nally JV. Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol. 2013 Mar; 79(3):175-83. PMID: 23320972.
      Citations: 11     Fields:    Translation:Humans
    129. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52. PMID: 23411425.
      Citations: 18     Fields:    Translation:Humans
    130. Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31; (1):CD006740. PMID: 23440810.
      Citations: 2     Fields:    Translation:Humans
    131. Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen SC, Li S, McCullough PA, Bakris G, Bomback A. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Mar; 61(3):404-12. PMID: 23260275.
      Citations: 11     Fields:    Translation:Humans
    132. Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167. PMID: 23217181.
      Citations: 13     Fields:    Translation:Humans
    133. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):7-14. PMID: 23211651.
      Citations: 25     Fields:    Translation:Humans
    134. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27. PMID: 22948230.
      Citations: 2     Fields:    Translation:Humans
    135. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75. PMID: 22910937.
      Citations: 86     Fields:    Translation:Humans
    136. Sullivan C, Leon JB, Sayre SS, Marbury M, Ivers M, Pencak JA, Bodziak KA, Hricik DE, Morrison EJ, Albert JM, Navaneethan SD, Reyes CM, Sehgal AR. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012 Oct; 7(10):1639-45. PMID: 22798540.
      Citations: 45     Fields:    Translation:Humans
    137. Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012 Jun 13; 344:e3533. PMID: 22695899.
      Citations: 20     Fields:    Translation:Humans
    138. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M. Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1155-62. PMID: 22554719.
      Citations: 90     Fields:    Translation:Humans
    139. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34. PMID: 22553369.
      Citations: 5     Fields:    Translation:Humans
    140. Strippoli GF, Vecchio M, Palmer S, De Berardis G, Craig J, Lucisano G, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Hegbrant J, Wollheim C, De Cosmo S, Manfreda VM. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012 Jun; 7(6):974-81. PMID: 22490876.
      Citations: 15     Fields:    Translation:Humans
    141. Fissell RB, Srinivas T, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9. PMID: 22422867.
      Citations: 6     Fields:    Translation:Humans
    142. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR, Schold JD. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond). 2012 Dec; 36(12):1585-90. PMID: 22290538.
      Citations: 13     Fields:    Translation:Humans
    143. Vecchio M, Palmer S, De Berardis G, Craig J, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Lucisano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Hegbrant J, Wollheim C, De Cosmo S, Manfreda VM, Strippoli GF. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012 Jun; 27(6):2479-88. PMID: 22207325.
      Citations: 9     Fields:    Translation:Humans
    144. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402. PMID: 21885787.
      Citations: 44     Fields:    Translation:Humans
    145. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2364-73. PMID: 21852664.
      Citations: 155     Fields:    Translation:Humans
    146. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43. PMID: 21816525.
      Citations: 26     Fields:    Translation:Humans
    147. Raina R, Simon JF, Marion CR, Valeria A, Navaneethan SD, Heresi GA, Guzman JA, Wehbe E, Nally JV. Unusual cases of hydronephrosis with retroperitoneal fibrosis: mystery revealed. NDT Plus. 2011 Oct; 4(5):313-317. PMID: 21969844.
      Citations:    
    148. Demirjian SG, Raina R, Bhimraj A, Navaneethan SD, Gordon SM, Schreiber MJ, Guzman JA. 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications. Am J Nephrol. 2011; 34(1):1-8. PMID: 21625080.
      Citations: 5     Fields:    Translation:HumansCells
    149. Wehbe E, Salem C, Simon JF, Navaneethan SD, Pohl M. IgA-dominant Staphylococcus infection-associated glomerulonephritis: case reports and review of the literature. NDT Plus. 2011 Jun; 4(3):181-5. PMID: 25984152.
      Citations:    
    150. Maione A, Navaneethan SD, Graziano G, Mitchell R, Johnson D, Mann JF, Gao P, Craig JC, Tognoni G, Perkovic V, Nicolucci A, De Cosmo S, Sasso A, Lamacchia O, Cignarelli M, Manfreda VM, Gentile G, Strippoli GF. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2011 Sep; 26(9):2827-47. PMID: 21372254.
      Citations: 21     Fields:    Translation:Humans
    151. Navaneethan SD, Hegbrant J, Strippoli GF. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2011 Mar; 20(2):146-52. PMID: 21245764.
      Citations: 2     Fields:    Translation:Humans
    152. Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD006023. PMID: 21328279.
      Citations: 22     Fields:    Translation:Humans
    153. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505. PMID: 21085061.
      Citations:    Fields:    Translation:Humans
    154. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010 Dec 08; (12):CD007747. PMID: 21154382.
      Citations: 4     Fields:    Translation:Humans
    155. Smith A, Palmer S, Johnson DW, Navaneethan S, Valentini M, Strippoli GF. How to conduct a randomized trial. Nephrology (Carlton). 2010 Dec; 15(8):740-6. PMID: 21175959.
      Citations: 4     Fields:    Translation:Humans
    156. Navaneethan SD, Palmer SC, Smith A, Johnson DW, Strippoli GF. How to design a randomized controlled trial. Nephrology (Carlton). 2010 Dec; 15(8):732-9. PMID: 21091924.
      Citations: 2     Fields:    Translation:Humans
    157. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504. PMID: 21115622.
      Citations: 9     Fields:    Translation:Humans
    158. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9. PMID: 21051745.
      Citations: 55     Fields:    Translation:Humans
    159. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010 Oct; 56(4):670-85. PMID: 20801572.
      Citations: 33     Fields:    Translation:Humans
    160. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011 Jan; 6(1):50-62. PMID: 20876671.
      Citations: 78     Fields:    
    161. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16. PMID: 20645941.
      Citations: 13     Fields:    Translation:Humans
    162. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010 Jul 06; 153(1):23-33. PMID: 20439566.
      Citations: 67     Fields:    Translation:Humans
    163. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli GF. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010 Jun; 5(6):985-95. PMID: 20498250.
      Citations: 12     Fields:    Translation:Humans
    164. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG, Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010 May 01; 105(9):1317-26. PMID: 20403486.
      Citations: 21     Fields:    Translation:Humans
    165. Navaneethan SD, Kandula P, Jeevanantham V, Nally JV, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010 Apr; 73(4):260-7. PMID: 20353733.
      Citations: 17     Fields:    Translation:Humans
    166. Dobre M, Demirjian S, Sehgal AR, Navaneethan SD. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011 Mar; 43(1):175-84. PMID: 20306131.
      Citations: 22     Fields:    Translation:Humans
    167. Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology (Carlton). 2010 Mar; 15(2):165-70. PMID: 20470274.
      Citations: 14     Fields:    Translation:Humans
    168. Palmer SC, Navaneethan SD, Strippoli GF. How to read a nephrology systematic review. Nephrology (Carlton). 2010 Mar; 15(2):158-64. PMID: 20470273.
      Citations: 1     Fields:    Translation:Humans
    169. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010 Mar; 20(3):308-15. PMID: 20217955.
      Citations: 24     Fields:    Translation:Humans
    170. Navaneethan SD, Schold JD, Srinivas TR. Metabolic syndrome and mild to moderate chronic kidney disease among minorities. Semin Nephrol. 2010 Jan; 30(1):51-8. PMID: 20116648.
      Citations: 1     Fields:    Translation:Humans
    171. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD006028. PMID: 19821351.
      Citations: 16     Fields:    Translation:Humans
    172. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1565-74. PMID: 19808241.
      Citations: 87     Fields:    Translation:Humans
    173. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37. PMID: 19692157.
      Citations: 38     Fields:    Translation:Humans
    174. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007004. PMID: 19588415.
      Citations: 14     Fields:    Translation:Humans
    175. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD004289. PMID: 19588351.
      Citations: 4     Fields:    Translation:Humans
    176. Navaneethan SD, Palmer SC, Schreiber MJ, Strippoli GF. Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder. Nephrology (Carlton). 2009 Jun; 14(4):363-6. PMID: 19563376.
      Citations:    Fields:    Translation:Humans
    177. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004289. PMID: 19370598.
      Citations: 11     Fields:    Translation:Humans
    178. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD005019. PMID: 19370615.
      Citations: 9     Fields:    Translation:Humans
    179. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD007784. PMID: 19370693.
      Citations: 51     Fields:    Translation:Humans
    180. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Mar; 4(3):542-51. PMID: 19261819.
      Citations: 63     Fields:    Translation:Humans
    181. Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009 Nov-Dec; 5(6):662-5. PMID: 19359221.
      Citations: 31     Fields:    Translation:Humans
    182. Navaneethan SD, Taylor J, Goldman B, Bose A. Anti-neutrophil cytoplasmic antibody associated crescentic IgA nephropathy in hematopoietic stem cell transplantation. Clin Nephrol. 2009 Jan; 71(1):59-62. PMID: 19203551.
      Citations: 4     Fields:    Translation:Humans
    183. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Feb; 4(2):261-72. PMID: 19073785.
      Citations: 22     Fields:    Translation:Humans
    184. Navaneethan SD, Lohmeier TE, Bisognano JD. Baroreflex stimulation: A novel treatment option for resistant hypertension. J Am Soc Hypertens. 2009 Jan-Feb; 3(1):69-74. PMID: 20409946.
      Citations:    Fields:    
    185. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant. 2009 Apr; 24(4):1260-6. PMID: 19033255.
      Citations: 23     Fields:    Translation:Humans
    186. Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Apr; 53(4):617-27. PMID: 19027212.
      Citations: 52     Fields:    Translation:Humans
    187. Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008 Dec; 52(6):1158-62. PMID: 18823685.
      Citations: 13     Fields:    Translation:Humans
    188. Ferrantino M, Navaneethan SD, Sloand JA. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int. 2008 Jul-Aug; 28(4):428-30. PMID: 18556394.
      Citations: 5     Fields:    Translation:HumansCells
    189. Navaneethan SD, Nigwekar SU. Lack of permanent access in late referrals and its implications: not to be forgotten. Am J Med. 2008 Jun; 121(6):e17; author reply e19. PMID: 18501211.
      Citations:    Fields:    Translation:Humans
    190. Nigwekar SU, Rajda J, Navaneethan SD. Hospitalist care and length of stay in patients with hip fracture: a systematic review. Arch Intern Med. 2008 May 12; 168(9):1010-1. PMID: 18474766.
      Citations: 5     Fields:    Translation:Humans
    191. Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008 Feb 25; 9:3. PMID: 18298850.
      Citations: 30     Fields:    Translation:Humans
    192. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008 Mar 22; 336(7645):645-51. PMID: 18299289.
      Citations: 90     Fields:    Translation:Humans
    193. Navaneethan SD, Viswanathan G, Strippoli GF. Meta-analysis of mycophenolate mofetil in IgA nephropathy. Nephrology (Carlton). 2008 Feb; 13(1):90. PMID: 18199113.
      Citations: 2     Fields:    Translation:Humans
    194. Navaneethan SD, Mooney R, Sloand J. Pseudo-anion gap acidosis. NDT Plus. 2008 Apr; 1(2):94-96. PMID: 28657030.
      Citations:    
    195. Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost. 2008 Jan; 99(1):38-43. PMID: 18217132.
      Citations: 11     Fields:    Translation:Humans
    196. Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008; 15(3):230-6. PMID: 18651415.
      Citations: 6     Fields:    Translation:Humans
    197. Navaneethan SD, Viswanathan G, Strippoli GF. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs. 2008; 68(15):2095-104. PMID: 18840001.
      Citations: 6     Fields:    Translation:Humans
    198. Navaneethan SD, Jeevanantham V, Nigwekar SU. Prevalence and predictors of lack of permanent vascular access in early referrals. Am J Kidney Dis. 2007 Oct; 50(4):687. PMID: 17900473.
      Citations:    Fields:    Translation:Humans
    199. Navaneethan SD, Viswanathan G, Strippoli GF. Choice of extracorporeal dialysis modality: can it be evidence based? Minerva Urol Nefrol. 2007 Sep; 59(3):261-7. PMID: 17912223.
      Citations:    Fields:    Translation:Humans
    200. Viswanathan G, Navaneethan SD. An overlooked differential diagnosis of acute chest pain. South Med J. 2007 Aug; 100(8):850. PMID: 17713317.
      Citations:    Fields:    Translation:Humans
    201. Navaneethan SD, Nigwekar S, Sengodan M, Anand E, Kadam S, Jeevanantham V, Grieff M, Choudhry W. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007; 106(3):c113-8. PMID: 17522473.
      Citations: 17     Fields:    Translation:Humans
    202. Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC. Haemoglobin targets: we were wrong, time to move on. Lancet. 2007 Feb 03; 369(9559):346-50. PMID: 17276756.
      Citations: 16     Fields:    Translation:Humans
    203. Nigwekar SU, Navaneethan SD. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc. 2007 Feb; 82(2):252-3. PMID: 17290737.
      Citations:    Fields:    Translation:Humans
    204. Bakare M, Shrivastava R, Jeevanantham V, Navaneethan SD. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J. 2007 Feb; 100(2):140-4. PMID: 17330682.
      Citations: 1     Fields:    Translation:Humans
    205. Jeevanantham V, Shrivastava R, Nannapaneni S, Khan A, Sengodan M, Nautiyal A, Navaneethan S, Hsi D. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea. Indian Heart J. 2007 Jan-Feb; 59(1):64-8. PMID: 19098338.
      Citations: 1     Fields:    Translation:Humans
    206. Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006 Nov-Dec; 20(6):769-75. PMID: 17100728.
      Citations: 44     Fields:    Translation:Humans
    207. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257. PMID: 17054288.
      Citations: 44     Fields:    Translation:Humans
    208. Strippoli GF, Navaneethan SD, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD003967. PMID: 17054191.
      Citations: 16     Fields:    Translation:Humans
    209. Navaneethan SD, Bonifati C, Schena FP, Strippoli GF. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006 Sep-Oct; 19(5):640-7. PMID: 17136694.
      Citations: 4     Fields:    Translation:Humans
    210. Navaneethan SD, Kannan VS, Osowo A, Shrivastava R, Singh S. Concomitant intracranial aneurysm and carotid artery stenosis: A therapeutic dilemma. South Med J. 2006 Jul; 99(7):757-8. PMID: 16866060.
      Citations: 8     Fields:    Translation:Humans
    211. Navaneethan SD, Querques M, Bonifati C, Strippoli GF. Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. Diabetes Educ. 2006 Jul-Aug; 32(4):596-602. PMID: 16873597.
      Citations:    Fields:    Translation:Humans
    212. Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD. Tacrolimus-associated hypomagnesemia in renal transplant recipients. Transplant Proc. 2006 Jun; 38(5):1320-2. PMID: 16797291.
      Citations: 9     Fields:    Translation:Humans
    213. Navaneethan SD, Pansini F, Strippoli GF. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med. 2006 May; 3(5):e123. PMID: 16719546.
      Citations: 2     Fields:    Translation:HumansCells
    214. Navaneethan SD, Nautiyal A, Abdel-Gadir K, Shrivastava R, Parameswaran G, DiSalle MR, Haley J. Hospitalist physicians as educators in a community hospital: the trainee's view. South Med J. 2006 May; 99(5):550-1. PMID: 16711328.
      Citations:    Fields:    Translation:Humans
    215. Osowo A, Fetten J, Navaneethan S. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006 Feb; 99(2):188-9. PMID: 16509562.
      Citations: 1     Fields:    Translation:HumansCells
    216. Rivero M, Karlic A, Navaneethan SD, Singh S. Possible cocaine-induced acute renal failure without rhabdomyolysis. J Nephrol. 2006 Jan-Feb; 19(1):108-10. PMID: 16523435.
      Citations: 3     Fields:    Translation:Humans
    217. Bonifati C, Pansini F, Torres DD, Navaneethan SD, Craig JC, Strippoli GF. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice. Int J Artif Organs. 2006 Jan; 29(1):41-9. PMID: 16485238.
      Citations: 3     Fields:    Translation:Humans
    218. Navaneethan SD, Singh S, Choudhry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005 Sep-Oct; 18(5):613-5. PMID: 16299690.
      Citations: 8     Fields:    Translation:Humans
    219. Navaneethan SD, Venkatesh S, Shrivastava R, Mehta J, Israel R. Recurrent pleural and pericardial effusions due to sarcoidosis. PLoS Med. 2005 Mar; 2(3):e63. PMID: 15783254.
      Citations: 4     Fields:    Translation:Humans
    220. Navaneethan S, Venkatesh S, Nannapaneni S, Shrivastava R. Educational intervention: a tool for decreasing medication errors. Int J Qual Health Care. 2005 Feb; 17(1):83. PMID: 15668315.
      Citations: 1     Fields:    Translation:Humans
    221. Navaneethan SD, Shrivastava R. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2004 Oct 18; (4):CD004289. PMID: 15495097.
      Citations: 2     Fields:    Translation:Humans
    NAVANEETHAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (543)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _